This study will evaluate the safety, biomarkers, and efficacy of tominersen compared with a placebo in participants with prodromal and early manifest Huntington’s Disease.
Inclusion Criteria:
Visit link below for more info:
| Ages Eligible for Study: | 25 Years to 50 Years (Adult) |
| Sexes Eligible for Study: | All |
Dr Michelle Rainka
Allison Emborsky
aemborsky@dentinstitute.com
716-558-3543
Want to participate in a study?
Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.